Dr Menghaney’s commitment to articulating and advocating for marginalised groups rings through every conversation with her. In this podcast, she links the role of the Indian pharmaceutical industry to the global movement on enabling access to HIV/AIDS drugs. She explains how the proposed waiver of intellectual property rights for COVID-19 related products seeks to correct for monopoly generated pricing and facilitate access to essential vaccines and therapeutics for all populations. In closing, she points to the power of collaborative action.
Dr Menghaney’s commitment to articulating and advocating for marginalised groups rings through every conversation with her. In this podcast, she links the role of the Indian pharmaceutical industry to the global movement on enabling access to HIV/AIDS drugs. She explains how the proposed waiver of intellectual property rights for COVID-19 related products seeks to correct for monopoly generated pricing and facilitate access to essential vaccines and therapeutics for all populations. In closing, she points to the power of collaborative action.